Tru Independence LLC Bristol Myers Squibb CO Transaction History

Tru Independence LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $59,702 - $69,933	-1,009 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $62,467 - $68,026	1,009 New	1,009 $67,000
Q1 2021 May 20, 2021	SELL	$59.34 - $66.74 $2,017 - $2,269	-34 Closed	0 $0
Q4 2020 Mar 09, 2021	SELL	$57.74 - $65.43 $3,810 - $4,318	-66 Reduced 66.0%	34 $2,000
Q3 2020 Nov 19, 2020	SELL	$57.43 - $63.64 $59 Million - $65.4 Million	-1,027,472 Reduced 99.99%	100 $6,000
Q2 2020 Aug 19, 2020	BUY	$54.82 - $64.09 $56.3 Million - $65.9 Million	1,027,572 New	1,027,572 $19,000
Q1 2020 May 19, 2020	SELL	$46.4 - $67.43 $50.2 Million - $72.9 Million	-1,081,698 Closed	0 $0
Q4 2019 May 19, 2020	BUY	$49.21 - $64.19 $53.2 Million - $69.4 Million	1,081,698 New	1,081,698 $49.3 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.